Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Fundus albipunctatus is a rare, genetic retinal dystrophy characterized by the presence of numerous small, round, yellowish-white retinal lesions that are distributed throughout the retina but spare the fovea. Patients present in childhood with non-progressive night blindness with prolonged cone and rod adaptation times. The macula may or may not be involved, which may result in a decrease of central visual acuity with age.
Features include: Retinal flecks, Nyctalopia, and Fundus albipunctatus.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 1 | Retinal flecks |
PRPH2 function has not been fully characterized.
Fundus albipunctatus is associated with mutations in the PRPH2 gene on chromosome 6.
RDH5 function has not been fully characterized.
Fundus albipunctatus is associated with mutations in the RDH5 gene on chromosome 12.
RHO function has not been fully characterized.
Fundus albipunctatus is associated with mutations in the RHO gene on chromosome 3.
RLBP1 function has not been fully characterized.
Fundus albipunctatus is associated with mutations in the RLBP1 gene on chromosome 15.
Genetic testing for PRPH2, RDH5, RHO, RLBP1 is available. Testing is considered confirmatory for diagnosis.
Estimated prevalence: Unknown (Unknown prevalence).
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
17 publications have been identified in PubMed for fundus albipunctatus. Research spans Case Report / Case Series (41%), Basic Science / Preclinical (29%), and Epidemiology / Natural History (18%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 7 | 41% |
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 12:48 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research |
5 |
29% |
Disease patterns and progression | 3 | 18% |
Research summaries | 1 | 6% |
New treatment approaches | 1 | 6% |
Baldaquí-Baeza A (2026). [PMID: 42065837](https://pubmed.ncbi.nlm.nih.gov/42065837/). *Doc Ophthalmol*. [Case Report / Case Series]
Dong Y (2026). [PMID: 41679585](https://pubmed.ncbi.nlm.nih.gov/41679585/). *Experimental eye research*. [Basic Science / Preclinical]
AlMoallem B (2026). [PMID: 42074478](https://pubmed.ncbi.nlm.nih.gov/42074478/). *Genes (Basel)*. [Case Report / Case Series]
Hayakawa T (2026). [PMID: 41902999](https://pubmed.ncbi.nlm.nih.gov/41902999/). *Jpn J Ophthalmol*. [Epidemiology / Natural History]
Das A (2025). [PMID: 41264291](https://pubmed.ncbi.nlm.nih.gov/41264291/). *JAMA ophthalmology*. [Case Report / Case Series]
Sundaramurthy S (2025). [PMID: 40551348](https://pubmed.ncbi.nlm.nih.gov/40551348/). *Acta ophthalmologica*. [Basic Science / Preclinical]
Abbass NJ (2025). [PMID: 40706695](https://pubmed.ncbi.nlm.nih.gov/40706695/). *American journal of ophthalmology*. [Case Report / Case Series]
Wolfram L (2025). [PMID: 41251530](https://pubmed.ncbi.nlm.nih.gov/41251530/). *Translational vision science & technology*. [Gene Therapy / Novel Therapeutics]
Yu X (2025). [PMID: 41463332](https://pubmed.ncbi.nlm.nih.gov/41463332/). *Biomolecules*. [Epidemiology / Natural History]
Naderi A (2025). [PMID: 39929173](https://pubmed.ncbi.nlm.nih.gov/39929173/). *Retinal cases & brief reports*. [Case Report / Case Series]